Diffuse large B-cell lymphoma of the central nervous system

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

4 events
Mar 2025Cord Blood-derived CAR-NK Cells Targeting CD19 for Refractory/Relapsed Central Nervous System Lymphoma

Second Affiliated Hospital, School of Medicine, Zhejiang University — PHASE1

TrialENROLLING BY INVITATION
Jan 2025High-dose Methotrexate Combined with Thiotepa and Zanubrutinib in the Treatment of Newly Diagnosed PCNSL (MTZ)

Sun Yat-sen University — PHASE2

TrialNOT YET RECRUITING
May 2021DALY II USA/ MB-CART2019.1 for DLBCL

Miltenyi Biomedicine GmbH — PHASE2

TrialRECRUITING
Dec 2017A Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric Antigen Receptor for Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

Fred Hutchinson Cancer Center — PHASE1, PHASE2

TrialACTIVE NOT RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Diffuse large B-cell lymphoma of the central nervous system.
Check the disease page for updates →

Clinical Trial Landscape

2 active trials
1Phase 2
1PHASE1, PHASE2
2Total recruiting
Search clinical trials for Diffuse large B-cell lymphoma of the central nervous system

Recent News & Research

No recent news articles indexed yet for Diffuse large B-cell lymphoma of the central nervous system.
Search PubMed for Diffuse large B-cell lymphoma of the central nervous system

Browse all Diffuse large B-cell lymphoma of the central nervous system news →

Specialist Network

Top 6 by expertise

View all Diffuse large B-cell lymphoma of the central nervous system specialists →

Quick Actions